The UK government's recent decision to move toward enabling human trials in which mitochondrial replacement from donor DNA would be used to treat mitochondrial disease in embryos has stirred up a predictable ethical debate. Does this step effectively green-light human germline modification, a step possibly towards even more profound human genetic engineering?

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An analysis of UK Biobank data finds hemochromatosis to be more prevalent than thought, according to the BBC.

An analysis finds that female biomedical researchers receive fewer prizes than male ones, and when they do win prizes, they are less prestigious.

In Nature this week: improved genomic analysis using a graph genome reference, tumor mutational burden could predict clinical response to immune checkpoint inhibitors, and more.

Federal researchers tell the Los Angeles Times that the shutdown is causing missed research opportunities as they try to keep their experiments going.